PMGC confirms compliance with Nasdaq's new MVLS requirement
It reports 8,095,835 shares outstanding and moves to correct inaccurate market data.
See the latest news and media coverage for NorthStrive. We track all announcements, press releases, and industry mentions in real time, all in one place.
Diversified holding company investing in American businesses
pmgcholdings.comLast updated
In short: NorthStrive launched a $100 million SPAC, expanded aerospace/defense manufacturing through acquisitions, and advanced its biosciences pipeline.
It reports 8,095,835 shares outstanding and moves to correct inaccurate market data.
A&B Aerospace will supply precision components for aerospace and defense under a two-year renewable deal, with a $500,000 equity investment in PAD Group.
Independent third-party testing will assess GPS-denied drone navigation technology under option to license.
The AI-driven program with Yuva Biosciences identified four compounds that increased ANT1 expression in human skeletal muscle cells.
PMGC's first sponsored SPAC adds a public-market acquisition vehicle to the holding company, targeting aerospace and defense, industrial technology, and critical supply chain manufacturersSponsor ...
Binding, interest-bearing payment plan converts PMGC's 5% net sales royalty into scheduled monthly cash payments to NorthStrive Biosciences...
If an emerging growth company, ... any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ... Item 1.01...
New Filings Extend EL-22 and EL-32 into Spaceflight-Associated Muscle Atrophy, Broadening NorthStrive's Myostatin and Activin A Intellectual Property Portfolio Across Human Weight-Loss, Space Health...
Track NorthStrive and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.